Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

Artificial intelligence in virtual screening: Models versus experiments
N. Arul Murugan, Gnana Ruba Priya, G. Narahari Sastry, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1913-1923
Closed Access | Times Cited: 70
Emerging applications of machine learning in genomic medicine and healthcare
Narjice Chafai, L. Bonizzi, Sara Botti, et al.
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 61, Iss. 2, pp. 140-163
Closed Access | Times Cited: 33
Machine Learning-based Virtual Screening for STAT3 Anticancer Drug Target
Abdul Wadood, Amar Ajmal, Muhammad Junaid, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 36, pp. 3023-3032
Closed Access | Times Cited: 31
Oncological drug discovery: AI meets structure-based computational research
Marina Gorostiola González, Antonius P. A. Janssen, Adriaan P. IJzerman, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 6, pp. 1661-1670
Open Access | Times Cited: 17
Revolution of Artificial Intelligence in Computational Chemistry Breakthroughs
Anjaneyulu Bendi, Sanchita Goswami, Prithu Banik, et al.
Chemistry Africa (2024) Vol. 7, Iss. 6, pp. 3443-3459
Closed Access | Times Cited: 3
Identification of Potential JNK3 Inhibitors: A Combined Approach Using Molecular Docking and Deep Learning-Based Virtual Screening
Chenpeng Yao, Zheyuan Shen, Liteng Shen, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1459-1459
Open Access | Times Cited: 6
Discovery of Novel c-Jun N-Terminal Kinase 1 Inhibitors from Natural Products: Integrating Artificial Intelligence with Structure-Based Virtual Screening and Biological Evaluation
Ruoqi Yang, Guiping Zhao, Bin Yan
Molecules (2022) Vol. 27, Iss. 19, pp. 6249-6249
Open Access | Times Cited: 10
Identification of a small molecule splicing inhibitor targeting UHM domains
Asaki Kobayashi, Marie‐Jeanne Clément, Pierrick Craveur, et al.
FEBS Journal (2021) Vol. 289, Iss. 3, pp. 682-698
Open Access | Times Cited: 14
Sequential virtual screening collaborated with machine-learning strategies for the discovery of precise medicine against non-small cell lung cancer
Muthu Kumar Thirunavukkarasu, V. Shanthi, K. Ramanathan
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 2, pp. 615-628
Closed Access | Times Cited: 4
Accelerated Hit Identification with Target Evaluation, Deep Learning and Automated Labs: Prospective Validation in IRAK1
Gintautas Kamuntavičius, Alvaro Prat, Tanya Paquet, et al.
(2024)
Open Access | Times Cited: 1
Accelerated hit identification with target evaluation, deep learning and automated labs: prospective validation in IRAK1
Gintautas Kamuntavičius, Alvaro Prat, Tanya Paquet, et al.
Journal of Cheminformatics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
EvaluationMaster: A GUI Tool for Structure-Based Virtual Screening Evaluation Analysis and Decision-Making Support
Zheyuan Shen, Roufen Chen, Jian Gao, et al.
Journal of Chemical Information and Modeling (2024) Vol. 65, Iss. 1, pp. 7-14
Closed Access | Times Cited: 1
Nitro Compounds Inhibit Breast Cancer Cell Proliferation, Migration, and Colony Formation: Molecular Docking, Molecular Dynamics Simulations and Pharmacological Properties
Ferah Cömert Önder, Nebahat Sahin, Gülce Davutlar, et al.
ChemistrySelect (2023) Vol. 8, Iss. 48
Closed Access | Times Cited: 3
Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation
Miaomiao Kong, Tao Wei, Bo Liu, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 18, pp. 1821-1837
Closed Access
Multiple Factors Determine the Oncolytic or Carcinogenic Effects of TLRs Activation in Cancer
Ying-Xiang Yang, C Jin, Anthony E. T. Yeo, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-28
Open Access
Accelerated Hit Identification with Target Evaluation, Deep Learning and Automated Labs: Prospective Validation in IRAK1
Gintautas Kamuntavičius, Alvaro Prat, Tanya Paquet, et al.
(2023)
Open Access | Times Cited: 1
Accelerated Hit Identification with Target Evaluation, Deep Learning and Automated Labs: Prospective Validation in IRAK1
Gintautas Kamuntavičius, Alvaro Prat, Tanya Paquet, et al.
(2023)
Open Access | Times Cited: 1
Artificial intelligence to speed up active compounds screening
Tânia Cova, Sandra C. C. Nunes, Alberto A. C. C. Pais
Elsevier eBooks (2023), pp. 271-284
Closed Access
Prospective Validation of HydraScreen: Virtual Screening and Hit Identification in IRAK1
Gintautas Kamuntavičius, Alvaro Prat, Tanya Paquet, et al.
(2023)
Open Access
Accelerated Hit Identification with Target Evaluation, Deep Learning and Automated Labs: Prospective Validation in IRAK1
Gintautas Kamuntavičius, Alvaro Prat, Tanya Paquet, et al.
(2023)
Open Access
Page 1

Scroll to top